- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00584064
Emergency/Compassionate Use PFO Occluder
April 9, 2019 updated by: Abbott Medical Devices
Emergency/compassionate use for the AMPLATZER PFO Occluder
Study Overview
Status
Approved for marketing
Conditions
Intervention / Treatment
Study Type
Expanded Access
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Emergency/compassionate use for patients not meeting the inclusion criteria for the AMPLATZER PFO Access Registry.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
December 20, 2007
First Submitted That Met QC Criteria
December 31, 2007
First Posted (Estimate)
January 2, 2008
Study Record Updates
Last Update Posted (Actual)
April 11, 2019
Last Update Submitted That Met QC Criteria
April 9, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AGA-006 - E/C
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patent Foramen Ovale
-
Abbott Medical DevicesActive, not recruitingPFO - Patent Foramen OvaleJapan
-
Carag AGCompleted
-
W.L.Gore & AssociatesRecruitingStroke | PFO - Patent Foramen OvaleUnited States
-
Wolfson Medical CenterUnknownClosure of the Foramen Ovale and Ductus ArteriosusIsrael
-
Chinese Academy of Medical Sciences, Fuwai HospitalRecruiting
-
Guangdong Provincial People's HospitalRecruitingMigraine | PFO - Patent Foramen OvaleChina
-
Hangzhou Dinova EP Technology Co., LtdNot yet recruiting
-
University of OregonEnrolling by invitationPatent Foramen OvaleUnited States
-
Lifetech Scientific (Shenzhen) Co., Ltd.CompletedPatent Foramen OvaleIreland, Germany
-
Lifetech Scientific (Shenzhen) Co., Ltd.Recruiting
Clinical Trials on Device closure with the AMPLATZER PFO Occluder
-
Abbott Medical DevicesNo longer availablePatent | Ductus | Arteriosus
-
Abbott Medical DevicesCompletedHeart Septal Defects, VentricularUnited States
-
Abbott Medical DevicesNo longer availableMembranous | Ventricular | Septal | Defects | VSD
-
Abbott Medical DevicesTerminatedMigraine | Patent Foramen Ovale | Migraine With Aura | PFOUnited Kingdom, Germany, Canada, Switzerland
-
SeptRx, Inc.UnknownHeart Septal Defects | Heart Defects, Congenital | Foramen Ovale, PatentGermany, France
-
Abbott Medical DevicesActive, not recruitingPFO - Patent Foramen OvaleJapan
-
Nobles Medical Technologies II IncSuspendedForamen Ovale, Patent | Stroke, IschemicUnited States, Italy
-
Abbott Medical DevicesCompletedPatent Ductus Arteriosus (PDA)United States
-
Abbott Medical DevicesCompleted